Variant report
Variant | esv3368352 |
---|---|
Chromosome Location | chr12:48883189-48883540 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr12:48882829-48883217 | GM12878 | blood: | n/a | chr12:48883023-48883034 |
2 | BCL11A | chr12:48882852-48883267 | GM12878 | blood: | n/a | n/a |
3 | BCLAF1 | chr12:48882751-48883247 | GM12878 | blood: | n/a | n/a |
4 | BHLHE40 | chr12:48882898-48883195 | GM12878 | blood: | n/a | n/a |
5 | CEBPB | chr12:48882593-48883325 | GM12878 | blood: | n/a | n/a |
6 | E2F4 | chr12:48882935-48883203 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | EBF1 | chr12:48882732-48883206 | GM12878 | blood: | n/a | chr12:48882931-48882942 |
8 | EP300 | chr12:48882814-48883236 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr12:48882788-48883206 | GM12878 | blood: | n/a | n/a |
10 | FOS | chr12:48882762-48883225 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr12:48882825-48883232 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr12:48882823-48883213 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr12:48882837-48883421 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOXM1 | chr12:48882633-48883283 | GM12878 | blood: | n/a | n/a |
15 | IRF4 | chr12:48882807-48883262 | GM12878 | blood: | n/a | n/a |
16 | MYC | chr12:48882797-48883582 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | MYC | chr12:48882824-48883500 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | NFIC | chr12:48882423-48883336 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr12:48882749-48883524 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | RUNX3 | chr12:48882700-48883303 | GM12878 | blood: | n/a | n/a |
21 | RUNX3 | chr12:48882835-48883231 | GM12878 | blood: | n/a | n/a |
22 | SP1 | chr12:48882789-48883194 | GM12878 | blood: | n/a | n/a |
23 | SRF | chr12:48882885-48883223 | GM12878 | blood: | n/a | chr12:48883067-48883080 chr12:48883069-48883078 chr12:48883068-48883082 chr12:48883068-48883079 |
24 | SRF | chr12:48882914-48883195 | GM12878 | blood: | n/a | chr12:48883067-48883080 chr12:48883069-48883078 chr12:48883068-48883082 chr12:48883068-48883079 |
25 | STAT3 | chr12:48882800-48883232 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | STAT3 | chr12:48882896-48883206 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr12:48882822-48883227 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr12:48882896-48883192 | GM12878 | blood: | n/a | n/a |
29 | TBP | chr12:48882671-48883205 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C12orf54 | TF binding region |
ENSG00000240443 | chromatin interactions |
ENSG00000177627 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200739829 | chr12:48883208-48883209 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs370397633 | chr12:48883209-48883210 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs56968979 | chr12:48883225-48883226 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs182756388 | chr12:48883287-48883288 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs35342454 | chr12:48883301-48883302 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs548974799 | chr12:48883302-48883303 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs140377696 | chr12:48883308-48883309 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs2731097 | chr12:48883311-48883312 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs556347734 | chr12:48883342-48883343 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs537974979 | chr12:48883381-48883382 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs576162553 | chr12:48883396-48883397 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs188122959 | chr12:48883406-48883407 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs555542939 | chr12:48883464-48883465 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs2731098 | chr12:48883468-48883469 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs377197542 | chr12:48883469-48883470 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs556288206 | chr12:48883485-48883486 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs189981274 | chr12:48883492-48883493 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs550607081 | chr12:48883508-48883509 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs34855520 | chr12:48883509-48883510 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:48881600-48883800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:48881600-48884000 | Enhancers | HMEC | breast |
3 | chr12:48882400-48884000 | Enhancers | GM12878-XiMat | blood |
4 | chr12:48882600-48883600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr12:48882800-48883200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr12:48882800-48883400 | Flanking Active TSS | NHEK | skin |
7 | chr12:48883000-48883200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr12:48883200-48884000 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr12:48883400-48884000 | Enhancers | NHEK | skin |